(Total Views: 45)
Posted On: 11/24/2025 2:03:24 PM
Post# of 29874
$CVM CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
https://finance.yahoo.com/news/cel-sci-multik...00923.html
https://finance.yahoo.com/news/cel-sci-multik...00923.html